Related Experiment Video

Updated: Aug 28, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

[Antibiotics in bacterial acute respiratory tract infection in children]

V K Tatochenko1, L K Katosova

  • 1Research Institute of Pediatrics, Russian Academy of Medical Sciences, Moscow.

Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]
|October 8, 1999
PubMed

Insights

This study examines antibiotic resistance in common respiratory pathogens like Pneumococcus and Haemophilus influenzae over 15 years. It provides guidance on choosing antibiotics for bacterial infections following viral respiratory illnesses, stressing reduced unnecessary antibiotic use.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Respiratory tract infections (RTIs) are frequently caused by viral pathogens, but bacterial complications like otitis, sinusitis, and pharyngitis necessitate targeted treatment.
  • Understanding antimicrobial susceptibility patterns of key respiratory pathogens is crucial for effective treatment strategies.
  • The increasing threat of antimicrobial resistance (AMR) requires careful consideration of antibiotic selection and judicious use.

Purpose of the Study:

  • To analyze trends in the antimicrobial susceptibility of prevalent respiratory tract pathogens, including Pneumococcus spp. and Haemophilus influenzae over the past 15 years.
  • To present current susceptibility data for Streptococcus spp., Staphylococcus spp., and Moraxella spp.
  • To provide evidence-based recommendations for the initial selection of antibacterial drugs for bacterial complications of acute viral respiratory tract infections.

Main Methods:

  • Retrospective analysis of antimicrobial susceptibility data for key respiratory pathogens over a 15-year period.
  • Review of current literature and original data to assess pathogen susceptibility.
  • Development of treatment guidelines based on collected data and established clinical practices.

Main Results:

  • Significant changes in the susceptibility patterns of Pneumococcus spp. and Haemophilus influenzae have been observed over the last 15 years.
  • Current data indicate varying susceptibility profiles for Streptococcus spp., Staphylococcus spp., and Moraxella spp.
  • The data support the need for updated recommendations on empirical antibiotic therapy for bacterial RTI complications.

Conclusions:

  • Antimicrobial resistance patterns necessitate ongoing surveillance and adaptation of treatment guidelines for respiratory pathogens.
  • Judicious antibiotic use is essential to combat the rising challenge of antimicrobial resistance.
  • Recommendations are provided for the appropriate initial treatment of bacterial complications of viral respiratory infections to optimize patient outcomes and preserve antibiotic efficacy.

More Related Videos

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Rapid Detection of Bacterial Pathogens Causing Lower Respiratory Tract Infections via Microfluidic-Chip-Based Loop-Mediated Isothermal Amplification06:11

Rapid Detection of Bacterial Pathogens Causing Lower Respiratory Tract Infections via Microfluidic-Chip-Based Loop-Mediated Isothermal Amplification

Published on: March 29, 2024

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...